• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰腺癌与纤维蛋白原贮积病

Pancreatic cancer and fibrinogen storage disease.

作者信息

Radhi J M, Lukie B E

机构信息

Department of Pathology, College of Medicine, University of Saskatchewan, Royal University Hospital, Saskatoon, Canada.

出版信息

J Clin Pathol. 1998 Nov;51(11):865-7. doi: 10.1136/jcp.51.11.865.

DOI:10.1136/jcp.51.11.865
PMID:10193333
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC500986/
Abstract

BACKGROUND

Ductal adenocarcinoma is the most common type of pancreatic carcinoma while squamous, carcinosarcoma, sarcoma, giant cell carcinoma, and clear cell types are all rare. Hepatocellular fibrinogen storage disease is also an uncommon disorder which may be associated with hepatocellular carcinoma. Two cases of pancreatic carcinoma were encountered in a family with fibrinogen storage disease, further raising the possibility of a predilection to malignancy in this unusual disorder. The tumour in one case was of the rare clear cell type. These two cases are the basis for this report.

METHODS

Sections were cut from retrieved paraffin embedded tissue and stained for routine histology. Immunohistochemistry using the avidin-biotin technique was applied for the expression of the markers p53 (D07), carcinoembryonic antigen (CEA), c-erbB-2, epithelial membrane antigen (EMA), and alpha-fetoprotein (AFP).

RESULTS

Both cases were adenocarcinoma of pancreatic ductal origin. The tumour in one case showed features of a clear cell carcinoma. The tumour cells expressed p53, CEA, and EMA immunoreactivity and were negative for c-erbB-2 and AFP.

CONCLUSIONS

Hepatocellular fibrinogen storage disease is rare and has been described in association with chronic hepatitis, cirrhosis, and rarely with hepatocellular carcinoma. This represents the first report of its association with carcinoma outside of the liver.

摘要

背景

导管腺癌是胰腺癌最常见的类型,而鳞状细胞癌、癌肉瘤、肉瘤、巨细胞癌和透明细胞型均较为罕见。肝细胞纤维蛋白原贮积病也是一种不常见的疾病,可能与肝细胞癌有关。在一个患有纤维蛋白原贮积病的家族中发现了两例胰腺癌,这进一步增加了这种罕见疾病易患恶性肿瘤的可能性。其中一例肿瘤为罕见的透明细胞型。这两例病例是本报告的基础。

方法

从回收的石蜡包埋组织中切片,进行常规组织学染色。采用抗生物素蛋白-生物素技术进行免疫组织化学检测,以检测p53(D07)、癌胚抗原(CEA)、c-erbB-2、上皮膜抗原(EMA)和甲胎蛋白(AFP)等标志物的表达。

结果

两例均为导管起源的胰腺腺癌。其中一例肿瘤表现为透明细胞癌特征。肿瘤细胞表达p53、CEA和EMA免疫反应性,而c-erbB-2和AFP为阴性。

结论

肝细胞纤维蛋白原贮积病罕见,已被描述与慢性肝炎、肝硬化相关,很少与肝细胞癌相关。这是其与肝外癌症相关的首次报告。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41e1/500986/4cf21fe57b3e/jclinpath00272-0076-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41e1/500986/c0812501fbeb/jclinpath00272-0076-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41e1/500986/9a5b197e02b5/jclinpath00272-0076-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41e1/500986/4cf21fe57b3e/jclinpath00272-0076-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41e1/500986/c0812501fbeb/jclinpath00272-0076-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41e1/500986/9a5b197e02b5/jclinpath00272-0076-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41e1/500986/4cf21fe57b3e/jclinpath00272-0076-c.jpg

相似文献

1
Pancreatic cancer and fibrinogen storage disease.胰腺癌与纤维蛋白原贮积病
J Clin Pathol. 1998 Nov;51(11):865-7. doi: 10.1136/jcp.51.11.865.
2
Immunohistochemistry of hepatocellular carcinoma associated with cirrhosis.肝硬化相关肝细胞癌的免疫组织化学
Ann Clin Lab Sci. 1984 Nov-Dec;14(6):467-73.
3
Clinical significance of serum p53 antigen in patients with pancreatic carcinomas.血清p53抗原在胰腺癌患者中的临床意义。
Gut. 1997 May;40(5):647-53. doi: 10.1136/gut.40.5.647.
4
Aberrant expression of a fetal glycoprotein 68 in hepatocellular carcinoma: a comparative study on the expression of alpha-fetoprotein and carcinoembryonic antigen.
Histol Histopathol. 2004 Jul;19(3):701-6. doi: 10.14670/HH-19.701.
5
Epithelial markers in pancreatic carcinoma: immunoperoxidase localisation of DD9, CEA, EMA and CAM 5.2.胰腺癌中的上皮标志物:DD9、癌胚抗原、上皮膜抗原和CAM 5.2的免疫过氧化物酶定位
J Clin Pathol. 1990 Jun;43(6):448-52. doi: 10.1136/jcp.43.6.448.
6
Pancreatic carcinoma surveillance in patients with familial melanoma.家族性黑色素瘤患者的胰腺癌监测
Arch Dermatol. 2003 Aug;139(8):1019-25. doi: 10.1001/archderm.139.8.1019.
7
Rethinking fibrinogen storage disease of the liver: ground glass and globular inclusions do not represent a congenital metabolic disorder but acquired collective retention of proteins.重新思考肝脏纤维蛋白原储存疾病:毛玻璃和球状内含物不代表先天性代谢紊乱,而是蛋白质的获得性集体潴留。
Hum Pathol. 2020 Jun;100:1-9. doi: 10.1016/j.humpath.2020.04.004. Epub 2020 Apr 21.
8
[Topoisomerase IIalpha and HER2/neu gene alterations and their correlation in pancreatic ductal adenocarcinomas].[拓扑异构酶IIα和HER2/neu基因改变及其在胰腺导管腺癌中的相关性]
Zhonghua Bing Li Xue Za Zhi. 2007 Feb;36(2):102-6.
9
Hilar cholangiocarcinoma and pancreatic ductal adenocarcinoma share similar histopathologies, immunophenotypes, and development-related molecules.肝门部胆管癌和胰腺导管腺癌具有相似的组织病理学、免疫表型和发育相关分子。
Hum Pathol. 2013 May;44(5):811-21. doi: 10.1016/j.humpath.2012.08.004. Epub 2012 Nov 5.
10
The Levels of Tumor Markers in Pancreatic Neuroendocrine Carcinoma and Their Values in Differentiation Between Pancreatic Neuroendocrine Carcinoma and Pancreatic Ductal Adenocarcinoma.胰腺神经内分泌癌中肿瘤标志物的水平及其在胰腺神经内分泌癌与胰腺导管腺癌鉴别中的价值。
Pancreas. 2018 Nov/Dec;47(10):1290-1295. doi: 10.1097/MPA.0000000000001181.

引用本文的文献

1
Primary Clear Cell Carcinoma of the Pancreas: A Systematic Review.胰腺原发性透明细胞癌:一项系统评价
Cureus. 2021 Jun 15;13(6):e15668. doi: 10.7759/cureus.15668.
2
Hereditary Hypofibrinogenemia with Hepatic Storage.遗传性低纤维蛋白原血症伴肝脏贮积症
Int J Mol Sci. 2020 Oct 22;21(21):7830. doi: 10.3390/ijms21217830.
3
Carbohydrate biomarkers for future disease detection and treatment.用于未来疾病检测与治疗的碳水化合物生物标志物。

本文引用的文献

1
Pancreatic carcinoma in perspective. A continuing challenge.
Cancer. 1996 Aug 1;78(3 Suppl):580-91. doi: 10.1002/(SICI)1097-0142(19960801)78:3<580::AID-CNCR38>3.0.CO;2-T.
2
Overexpression of p53 protein in adenocarcinoma of the pancreas.
Am J Clin Pathol. 1994 Jun;101(6):684-8. doi: 10.1093/ajcp/101.6.684.
3
Pancreatic carcinoma in brothers.兄弟患胰腺癌
Ann Intern Med. 1982 Aug;97(2):282. doi: 10.7326/0003-4819-97-2-282_1.
4
Sci China Chem. 2010;53(1):3-20. doi: 10.1007/s11426-010-0021-3. Epub 2010 Feb 7.
4
Carbohydrate recognition by boronolectins, small molecules, and lectins.硼酸酯结合蛋白、小分子和凝集素对碳水化合物的识别。
Med Res Rev. 2010 Mar;30(2):171-257. doi: 10.1002/med.20155.
Pathology and pathogenesis of diseases of the pancreas.
胰腺疾病的病理学与发病机制
Am J Pathol. 1982 Apr;107(1):99-121.
5
Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.抗生物素蛋白-生物素-过氧化物酶复合物(ABC)在免疫过氧化物酶技术中的应用:ABC法与未标记抗体(PAP)法的比较。
J Histochem Cytochem. 1981 Apr;29(4):577-80. doi: 10.1177/29.4.6166661.
6
Hepatocellular fibrinogen storage in familial hypofibrinogenemia.家族性低纤维蛋白原血症中的肝细胞纤维蛋白原储存
Virchows Arch B Cell Pathol Incl Mol Pathol. 1981;36(2-3):247-55. doi: 10.1007/BF02912070.
7
Pancreatic adenocarcinoma in an adolescent male with Peutz-Jeghers syndrome.一名患有黑斑息肉综合征的青少年男性的胰腺腺癌。
Hum Pathol. 1986 Jan;17(1):97-9. doi: 10.1016/s0046-8177(86)80163-0.
8
Familial pancreatic adenocarcinoma in three generations. A case report and a review of the literature.三代家族性胰腺腺癌。病例报告及文献综述。
Cancer. 1987 May 1;59(9):1661-4. doi: 10.1002/1097-0142(19870501)59:9<1661::aid-cncr2820590923>3.0.co;2-h.
9
Clear cell carcinoma of the pancreas.胰腺透明细胞癌
Acta Pathol Jpn. 1987 Sep;37(9):1521-6. doi: 10.1111/j.1440-1827.1987.tb02273.x.
10
Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer.c-erbB-2癌蛋白的表达:人类乳腺癌的一种预后指标。
Cancer Res. 1989 Apr 15;49(8):2087-90.